Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Diclofenac epolamine is a topical nonsteroidal anti-inflammatory drug (NSAID) specifically formulated for transdermal absorption to treat acute pain from minor strains, sprains, and contusions.
Name
Diclofenac Epolamine
Raw Name
DICLOFENAC EPOLAMINE
Category
Other
Drug Count
3
Variant Count
10
Last Verified
February 17, 2026
RxCUI
855626, 855628, 2372911, 2385117
UNII
X5F8EKL9ZG
About Diclofenac Epolamine
Diclofenac epolamine is a topical nonsteroidal anti-inflammatory drug (NSAID) specifically formulated for transdermal absorption to treat acute pain from minor strains, sprains, and contusions.
Detailed information about Diclofenac Epolamine
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Diclofenac Epolamine.
Physicians often classify diclofenac epolamine as a topical analgesic and anti-inflammatory agent. It is designed for patients who require localized pain relief but may wish to minimize the gastrointestinal or systemic risks associated with oral NSAID therapy. However, it is vital to understand that even though it is applied topically, it is still absorbed into the body and carries many of the same class-wide risks as other NSAIDs. Your healthcare provider will determine if this specific salt form is appropriate for your clinical needs, particularly if you have a history of sensitivity to other anti-inflammatory medications.
At the molecular level, diclofenac epolamine functions as an inhibitor of the enzyme cyclooxygenase (COX). There are two primary isoforms of this enzyme: COX-1 and COX-2. These enzymes are responsible for the conversion of arachidonic acid into prostaglandins, which are lipid compounds that act as mediators of inflammation, pain, and fever. By inhibiting these enzymes, diclofenac reduces the production of prostaglandins at the site of application.
Specifically, diclofenac is a non-selective NSAID, meaning it targets both COX-1 (which is involved in protecting the stomach lining and supporting kidney function) and COX-2 (which is primarily induced during injury and inflammation). The epolamine salt acts as a penetration enhancer; its chemical structure allows the diclofenac molecule to bypass the stratum corneum (the outermost layer of the skin) more efficiently than other salt forms like diclofenac sodium or potassium. Once the medication reaches the underlying soft tissue, it stabilizes cell membranes and inhibits the chemotaxis (movement) of inflammatory cells, thereby reducing swelling and localized tenderness.
The pharmacokinetic behavior of diclofenac epolamine is what distinguishes it from its oral counterparts. Because it is applied topically, it avoids the 'first-pass metabolism' by the liver that occurs with oral pills.
Diclofenac epolamine is FDA-approved for specific indications related to musculoskeletal pain. Healthcare providers typically prescribe it for:
Diclofenac epolamine is primarily available in the following dosage forms:
> Important: Only your healthcare provider can determine if Diclofenac Epolamine is right for your specific condition. Do not apply this medication to open wounds, rashes, or infected skin.
For the treatment of acute pain due to minor strains, sprains, and contusions, the standard adult dosage for the diclofenac epolamine 1.3% topical patch is:
The safety and effectiveness of diclofenac epolamine in pediatric patients have not been fully established.
While systemic absorption is low, diclofenac epolamine should be used with caution in patients with advanced renal (kidney) disease. If a patient has a creatinine clearance of less than 30 mL/min, healthcare providers may advise against use due to the risk of further deteriorating kidney function.
Patients with severe hepatic (liver) impairment should be monitored closely. While the liver metabolizes very little of the topically absorbed drug, the underlying risk of NSAID-induced hepatotoxicity remains a theoretical concern.
Geriatric patients (65 years and older) are at a higher risk for NSAID-related complications, including gastrointestinal bleeding and cardiovascular events. Healthcare providers typically recommend using the lowest effective dose for the shortest possible duration in this population.
To ensure the medication works effectively and to minimize the risk of side effects, follow these application steps:
If you forget to apply a patch at the scheduled time, apply it as soon as you remember. However, if it is almost time for your next scheduled application, skip the missed dose and return to your regular 12-hour cycle. Do not apply two patches at once to 'make up' for a missed dose.
An overdose from a topical patch is highly unlikely when used as directed. However, if multiple patches are applied or if the medication is accidentally ingested, systemic toxicity can occur. Signs of NSAID overdose include:
In the event of accidental ingestion, contact a Poison Control Center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or apply the patch to more than one area at a time without medical guidance.
The most frequently reported side effects associated with diclofenac epolamine are localized to the site of application. Because the drug is delivered through the skin, the 'dermal' interface often reacts to the adhesive or the active ingredient. Common symptoms include:
These symptoms are usually mild and resolve shortly after the patch is removed or the treatment course ends.
Some patients may experience systemic reactions even with topical application, as a small percentage of the drug enters the bloodstream:
Rare but documented side effects include:
> Warning: Stop taking Diclofenac Epolamine and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of diclofenac epolamine (beyond the recommended 14 days) increases the risk of cumulative systemic absorption. Long-term risks include:
As with all prescription NSAIDs, diclofenac epolamine carries the FDA's most serious warning:
Report any unusual symptoms to your healthcare provider immediately to ensure your safety during treatment.
Diclofenac epolamine is a prescription-strength medication that requires careful screening by a healthcare professional. It is not a simple 'bandage' for pain; it is a pharmacologically active system that interacts with your body's chemistry. You should inform your doctor if you have a history of heart disease, stomach ulcers, asthma, or kidney problems before starting this medication.
Cardiovascular Thrombotic Events: Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, myocardial infarction, and stroke, which can be fatal. All NSAIDs, both COX-2 selective and nonselective, may have a similar risk. Patients with known CV disease or risk factors for CV disease may be at greater risk.
Gastrointestinal Bleeding, Ulceration, and Perforation: NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious GI events.
If you are prescribed diclofenac epolamine for a duration longer than two weeks, or if you have underlying health conditions, your doctor may require:
While topical diclofenac is unlikely to cause significant impairment, rare side effects such as dizziness or somnolence (sleepiness) have been reported. Do not drive or operate heavy machinery until you know how this medication affects you.
Combining alcohol with NSAIDs significantly increases the risk of gastrointestinal irritation and bleeding. It is generally advised to avoid or strictly limit alcohol consumption while using diclofenac epolamine to protect your stomach lining.
There is no known 'withdrawal syndrome' associated with stopping diclofenac epolamine. However, if you are using it for a chronic condition off-label, stopping suddenly may result in a return of inflammatory pain. Always consult your doctor before ending a prescribed course of treatment.
> Important: Discuss all your medical conditions with your healthcare provider before starting Diclofenac Epolamine to ensure it is the safest option for your pain management.
Certain medications should never be used alongside diclofenac epolamine due to the risk of severe adverse reactions:
Because diclofenac epolamine is applied topically, food does not typically affect its absorption or efficacy. However, the use of Alcohol is a major concern. Alcohol irritates the stomach lining and, when combined with the systemic presence of diclofenac, significantly raises the risk of peptic ulcers and gastric hemorrhage.
Many natural supplements have anti-platelet properties that can exacerbate the bleeding risks of diclofenac epolamine:
Diclofenac epolamine does not typically interfere with common laboratory tests, but it may cause false-positive results in certain urine drug screens for other substances, or it may lead to elevated liver enzymes (ALT/AST) on a metabolic panel.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the best way to prevent dangerous drug-drug interactions.
Diclofenac epolamine must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician include:
There is a high degree of cross-sensitivity between different NSAIDs. If you are allergic to ibuprofen (Advil, Motrin) or naproxen (Aleve), there is a significant chance you will also be sensitive to diclofenac epolamine. Always inform your clinician of any drug allergies before starting topical NSAID therapy.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Diclofenac Epolamine to ensure no contraindications are present.
The use of diclofenac epolamine during pregnancy requires extreme caution and is generally avoided unless the benefits clearly outweigh the risks.
It is not known whether topically applied diclofenac epolamine is excreted in human milk. However, since many drugs are excreted in milk and systemic absorption of diclofenac occurs, caution should be exercised. If a nursing mother must use the patch, it should not be applied to the breast or chest area to prevent the infant from coming into direct contact with the medication.
Diclofenac epolamine patches are not generally recommended for use in patients under the age of 18. The safety profile and the appropriate dosing for the developing skin and metabolic systems of children have not been established in large-scale clinical trials. Use in adolescents should only occur under the direct supervision of a healthcare provider.
Clinical studies of diclofenac epolamine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, general clinical experience with NSAIDs suggests that elderly patients are at a significantly higher risk for:
In patients with mild to moderate renal impairment, the systemic levels of diclofenac may be slightly higher, but usually do not require a dose adjustment for the topical patch. However, in cases of severe renal disease, the drug should be avoided entirely to prevent the risk of acute renal failure (ARF) or hyperkalemia (high potassium).
Patients with mild to moderate hepatic impairment (Child-Pugh Class A or B) generally do not require dose adjustments. However, those with severe hepatic cirrhosis (Child-Pugh Class C) should be monitored for signs of worsening liver function, as the liver is responsible for clearing the small amount of drug that reaches the systemic circulation.
> Important: Special populations require individualized medical assessment. Always disclose your age, pregnancy status, or underlying organ dysfunction to your doctor.
Diclofenac epolamine is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. The primary mechanism involves the potent inhibition of the enzyme cyclooxygenase (COX). By blocking the COX-1 and COX-2 isoforms, diclofenac prevents the conversion of arachidonic acid into various prostaglandins (PGE2, PGI2, PGF2α) and thromboxanes. Prostaglandins are the primary sensitizers of nociceptors (pain receptors) and mediators of the inflammatory response. By reducing their concentration at the site of injury, diclofenac epolamine raises the pain threshold and reduces localized swelling and heat.
The pharmacodynamics of the topical patch are characterized by a localized effect. While oral diclofenac produces a systemic peak that affects the whole body, the epolamine patch creates a concentration gradient. The drug moves from the high-concentration reservoir in the patch into the dermis and then into the underlying muscle or joint tissue. The onset of pain relief is typically observed within 1 to 4 hours, with maximum effect reached after repeated applications (steady state) over 2-3 days.
| Parameter | Value |
|---|---|
| Bioavailability | ~6% (relative to oral) |
| Protein Binding | >99% (to Albumin) |
| Half-life (Elimination) | ~12 hours (topical) |
| Tmax (Time to peak) | 10–20 hours |
| Metabolism | Hepatic (CYP2C9) |
| Excretion | Renal 65%, Fecal 35% |
Diclofenac epolamine is classified as a nonsteroidal anti-inflammatory drug (NSAID) and a topical analgesic. It belongs to the same therapeutic family as ibuprofen, naproxen, and indomethacin. However, its specific salt formulation places it in a niche category of 'transdermal NSAID delivery systems' alongside products like diclofenac sodium gels and ibuprofen creams.
Medications containing this ingredient
Common questions about Diclofenac Epolamine
Diclofenac epolamine is primarily used for the topical treatment of acute pain resulting from minor musculoskeletal injuries. This includes conditions such as muscle strains, ligament sprains, and contusions (bruises). Unlike oral medications that circulate throughout the entire body, this medication is applied as a patch directly to the site of pain to provide localized relief. It works by reducing the production of prostaglandins, which are chemicals in the body that signal pain and cause inflammation. Healthcare providers often prefer this topical form for patients who need effective pain relief but want to minimize the risk of stomach upset associated with oral pills. It is typically used for short-term relief, usually for up to two weeks.
The most common side effects of diclofenac epolamine are localized skin reactions at the site where the patch is applied. Patients frequently report itching, redness, or a mild burning sensation under the patch. Some individuals may also experience 'contact dermatitis,' which involves the development of small bumps or a flaky rash. Because a small amount of the drug is absorbed into the bloodstream, some people might experience mild systemic effects like a headache, nausea, or dizziness. These side effects are generally mild and go away once the patch is removed. If you notice severe blistering or a rash that spreads beyond the patch area, you should contact your healthcare provider immediately.
It is generally recommended to avoid or strictly limit alcohol consumption while using any form of diclofenac, including the epolamine patch. Even though the patch is applied topically, the active drug still enters your systemic circulation. Alcohol is known to irritate the lining of the stomach and intestines. When combined with an NSAID like diclofenac, the risk of developing a stomach ulcer or experiencing gastrointestinal bleeding increases significantly. For your safety, it is best to discuss your alcohol intake with your doctor. If you have a history of heavy alcohol use, you may be at a much higher risk for serious internal bleeding while using this medication.
Diclofenac epolamine is generally not recommended during pregnancy, especially during the third trimester. Starting at 30 weeks of gestation, using NSAIDs like diclofenac can cause a serious heart defect in the developing fetus known as premature closure of the ductus arteriosus. During the first and second trimesters, the drug should only be used if your doctor determines that the potential benefit outweighs the potential risk to the baby. Some studies suggest that NSAID use in early pregnancy might be linked to an increased risk of miscarriage. Always inform your healthcare provider if you are pregnant or planning to become pregnant before using this medication. They will likely recommend safer alternatives for pain management during your pregnancy.
The onset of pain relief from a diclofenac epolamine patch is typically gradual rather than immediate. Most patients begin to feel a reduction in pain within 1 to 4 hours after the first application. However, the maximum anti-inflammatory effect usually takes 2 to 3 days of consistent use (applying a new patch every 12 hours) to reach 'steady-state' levels in the local tissue. It is important to follow the prescribed schedule even if you do not feel total relief right away. If your pain does not improve or if it gets worse after 7 days of treatment, you should consult your healthcare provider for a re-evaluation of your injury. Do not use the patch for more than 14 days unless specifically directed by a doctor.
Yes, you can generally stop using diclofenac epolamine patches suddenly without experiencing withdrawal symptoms. This medication does not cause physical dependence like opioid pain relievers do. However, if you stop using the patch before your injury has fully healed, the pain and inflammation may return or intensify. It is always best to complete the full course of treatment as prescribed by your healthcare provider. If you are stopping the medication because of a side effect, such as skin irritation or stomach pain, inform your doctor so they can suggest an alternative treatment. There is no need to 'taper' or gradually reduce the use of topical diclofenac.
If you miss a dose of diclofenac epolamine, you should apply a new patch as soon as you remember. If it is almost time for your next scheduled dose (for example, within a few hours), skip the missed dose and simply apply the next patch at your usual time. You should never apply two patches at the same time to make up for a missed application, as this increases the risk of skin irritation and systemic side effects. Maintaining a consistent 12-hour schedule helps keep a steady level of the medication at the site of your injury. If you find it difficult to remember your doses, setting a phone alarm for the morning and evening can be a helpful strategy.
Diclofenac epolamine does not typically cause weight gain in the form of increased body fat. However, like all NSAIDs, it can cause the body to retain excess fluid and sodium, which may lead to 'water weight' gain or swelling (edema) in the ankles, feet, or hands. This fluid retention is usually mild in healthy individuals but can be more significant in people with pre-existing heart or kidney problems. If you notice a sudden, unexplained increase in weight or significant swelling while using the patch, you should contact your doctor. This could be a sign that the medication is affecting your kidney function or heart health, requiring a medical assessment.
Diclofenac epolamine can interact with several other medications, so caution is necessary. You should avoid using it with other NSAIDs, such as oral ibuprofen or naproxen, as this increases the risk of serious side effects like stomach bleeding and kidney damage. It can also interfere with the effectiveness of blood pressure medications (like ACE inhibitors or diuretics) and increase the toxicity of drugs like lithium or methotrexate. If you are taking blood thinners like warfarin or aspirin, the risk of bleeding is significantly higher. Always provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking to ensure there are no dangerous interactions.
Yes, diclofenac epolamine 1.3% topical patches are available as a generic medication in the United States. The brand-name version of this patch is known as Flector. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name product. They must also demonstrate 'bioequivalence,' meaning they work in the same way and provide the same clinical benefit. Choosing the generic version can often be a more cost-effective option for patients. You should check with your pharmacist or insurance provider to see if the generic form is covered under your specific plan.